Alkermes (ALKS) Divestments (2015)
Alkermes' (ALKS) quarterly Divestments came in at -$301000.0 in Q4 2015, down 1257.69% quarter-over-quarter from $26000.0 in Q3 2015.
Powered by 
Analysis
Alkermes (ALKS) Divestments (2015) Analysis & Trends
Alkermes (ALKS) has reported Divestments for 1 consecutive years, with -$301000.0 the latest figure, recorded in Q4 2015.
- On a quarterly basis, Divestments changed N/A year-over-year to -$301000.0 in Q4 2015; TTM through Sep 2025 was -$301000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.7 million, down 98.26% from the prior year.
- Divestments was -$301000.0 for Q4 2015 at Alkermes, down from $26000.0 in the prior quarter.
- Over five years, Divestments peaked at $26000.0 in Q3 2015 and troughed at -$301000.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1.88 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | - |